Glaxo Smithkline Consumer Nigeria PLC operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Glaxo Smithkline Consumer Nigeria PLC with three other
pharmaceutical manufacturers in Africa:
Ste Promotion Pharmaceutique du Maghreb SA
sales of 522.45 million Moroccan Dirhams [US$56.07 million]
Societe Adwya SA
(105.64 million Tunisian Dinars [US$38.30 million]
of which 57%
was Pharmacy), and
Unite de Fabrication de Medicaments SA
based in TUNISIA
(107.21 million Tunisian Dinars [US$38.87 million]
During the year ended December of 2019, sales at
Glaxo Smithkline Consumer Nigeria PLC were 20.76 billion Nigerian Naira (US$54.39 million).
increase of 12.8%
versus 2018, when the company's sales were 18.41 billion Nigerian Naira.
This was the third consecutive year of growth at Glaxo Smithkline Consumer Nigeria PLC.